LD-2 disclosure · 3rd Quarter - Report
STUDENTS FOR SENSIBLE DRUG POLICY
Coverage · No income or expenses were reported on this filing.
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Drug policy reform advocacy
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueCivil Rights/Civil Liberties
Marijuana descheduling / legalization (MORE Act of 2021, Cannabis Administration and Opportunity Act) EQUAL Act (sentencing reduction) Eliminating appropriations for aerial crop fumigation in Colombia
Lobbyistsmr ROBERT ALAN HOFMANN
TargetedSENATE · HOUSE OF REPRESENTATIVES